Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

Wei Zhang,Weiwei Wang,Junlu Wu,Jiale Tian,Wenhui Yan,Yi Yuan,Yiwen Yao,Anquan Shang,Wenqiang Quan

DOI: https://doi.org/10.3389/fonc.2022.1118042

2022-12-15

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.942964.].

What problem does this paper attempt to address?

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Mingchuang Zhu,Qingpeng Zeng,Tao Fan,Yuanyuan Lei,Feng Wang,Sufei Zheng,Xinfeng Wang,Hui Zeng,Fengwei Tan,Nan Sun,Qi Xue,Jie He

DOI: https://doi.org/10.3389/fimmu.2022.909105

IF: 7.3

2022-05-04

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783495.].

immunology
Corrigendum: Lipid metabolism and tumor immunotherapy

Yue Wang,Zongjin Guo,Adamu Danbala Isah,Shuangwei Chen,Yongfei Ren,Huazhong Cai

DOI: https://doi.org/10.3389/fcell.2024.1349379

IF: 5.5

2024-01-26

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2023.1187989.].

cell biology,developmental biology
Corrigendum: T lymphocyte cell: A pivotal player in lung cancer

Yanan Wu,Meng Yuan,Chenlin Wang,Yanfei Chen,Yan Zhang,Jiandong Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1166352

IF: 7.3

2023-02-21

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1102778.].

immunology
Corrigendum: Lipid metabolism in tumor immunology and immunotherapy

Lisa K. Duong,Halil Ibrahim Corbali,Thomas S. Riad,Shonik Ganjoo,Selene Nanez,Tiffany Voss,Hampartsoum B. Barsoumian,James Welsh,Maria Angelica Cortez

DOI: https://doi.org/10.3389/fonc.2023.1358498

IF: 4.7

2024-01-08

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1187279.].

oncology
Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Anli Yang,Ying Zhou,Yanan Kong,Xiaoli Wei,Feng Ye,Lijuan Zhang,Xian Zhong,Mingyue Li,Shilin Lu,Xin An,Weikai Xiao

DOI: https://doi.org/10.3389/fimmu.2024.1372991

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.704557.].

immunology
Corrigendum: Immune Tolerance Induced by Hematopoietic Stem Cell Infusion after HLA Identical Sibling Kidney Transplantation

Hongfeng Huang,Qixia Shen,Jingyi Zhou,Xiuyan Yang,Qiuqin Cai,Jia Shen,Shi Feng,Wenqing Xie,Hong Jiang,Jianghua Chen

DOI: https://doi.org/10.3389/fimmu.2022.1052676

IF: 7.3

2022-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.995243.].
Corrigendum: Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis

Qiang Zhang,Hua Zhong,Yinchun Fan,Qian Liu,Jiancheng Song,Shengtao Yao,Fang Cao

DOI: https://doi.org/10.3389/fbioe.2020.599544

IF: 5.7

2020-10-23

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2020.00592.].

multidisciplinary sciences
Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Pingping Ren,Luying Lu,Shasha Cai,Jianghua Chen,Weiqiang Lin,Fei Han

DOI: https://doi.org/10.3389/fimmu.2024.1513491

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.713540.].
Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes

Chunbo Li,Keqin Hua

DOI: https://doi.org/10.3389/fimmu.2024.1386072

IF: 7.3

2024-02-23

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.897366.].

immunology
Corrigendum: Interpreting flow cytometry with caution: a case report of follicular lymphoma in leukemic phase misdiagnosed as chronic lymphocytic leukemia

Yuan Ren,Congwei Jia,Miao Chen,Wei Wang,Wei Zhang

DOI: https://doi.org/10.3389/fonc.2023.1229649

IF: 4.7

2023-06-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1170598.].

oncology
Corrigendum: Exosomes: Potential biomarkers and functions in head and neck squamous cell carcinoma

Ting Li,Juan Li,Haitao Wang,Jiayu Zhao,Mingze Yan,Hongjiang He,Shan Yu

DOI: https://doi.org/10.3389/fmolb.2022.1056179

IF: 6.113

2022-11-03

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2022.881794.].

biochemistry & molecular biology
Corrigendum: Identification of Microtube-Associated Biomarkers in Diffuse Large B-cell Lymphoma and Prognosis Prediction.

Wenqi Wu,Su Liu,Linyan Tian,Cheng Li,Yanan Jiang,Jinhuan Wang,Yangyang Lv,Jing Guo,Donghui Xing,Yixin Zhai,Huimeng Sun,Yuhang Li,Luying Zhang,Xiang He,Kaiping Luo,Hongjie Zhan,Zhigang Zhao

DOI: https://doi.org/10.3389/fgene.2023.1180076

IF: 3.7

2023-01-01

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1092678.].
Corrigendum: Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma

Fang Tong,Lifa Xu,Sheng Xu,Mingming Zhang

DOI: https://doi.org/10.3389/fgene.2022.1050296

IF: 3.7

2022-10-25

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.834935.].

genetics & heredity
Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Xinyao Hu,Hua Zhu,Shi Feng,Chaoqun Wang,Yingze Ye,Xiaoxing Xiong

DOI: https://doi.org/10.3389/fgene.2022.1117731

IF: 3.7

2023-01-16

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.1006357.].

genetics & heredity
Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Xu-Sheng Liu,Lu-Meng Zhou,Ling-Ling Yuan,Yan Gao,Xue-Yan Kui,Xiao-Yu Liu,Zhi-Jun Pei

DOI: https://doi.org/10.3389/fimmu.2021.751004

IF: 7.3

2021-08-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.724741.].

immunology
Corrigendum: Exosomal CD44 transmits lymph node metastatic capacity between gastric cancer cells via YAP-CPT1A-mediated FAO reprogramming

Mei Wang,Wanjun Yu,Xiaoli Cao,Hongbing Gu,Jiaying Huang,Chen Wu,Lin Wang,Xin Sha,Bo Shen,Ting Wang,Yongliang Yao,Wei Zhu,Feng Huang

DOI: https://doi.org/10.3389/fonc.2024.1495349

2024-10-11

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.860175.].
Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors

Tao Hou,Shun Jiang,Yapeng Wang,Yangchun Xie,Haixia Zhang,Yeqian Feng,Fang Ma,Jin’an Ma,Xianling Liu,Chunhong Hu

DOI: https://doi.org/10.3389/fonc.2021.705406

IF: 4.7

2021-06-02

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.608300.].

oncology
Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Meng-Xia Zhang,Li Wang,Lei Zeng,Zi-Wei Tu

DOI: https://doi.org/10.3389/fonc.2021.670714

IF: 4.7

2021-03-18

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.605777.].

oncology
Corrigendum: Cuproptosis Key Gene FDX1 is a Prognostic Biomarker and Associated with Immune Infiltration in Glioma.

Hanwen Lu,Liwei Zhou,Bingchang Zhang,Yuanyuan Xie,Huiyin Yang,Zhanxiang Wang

DOI: https://doi.org/10.3389/fmed.2023.1244638

IF: 3.9

2023-01-01

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2022.939776.].
Corrigendum: Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis

Zhe Zhuang,Yan Zhang,Xiao Zhang,Meifen Zhang,Dongmei Zou,Li Zhang,Congwei Jia,Wei Zhang

DOI: https://doi.org/10.3389/fonc.2022.1104236

IF: 4.7

2023-01-27

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.955080.].

oncology

Corrigendum: Immune cell-lipoprotein imbalance as a marker for early diagnosis of non-small cell lung cancer metastasis

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Corrigendum: Lipid metabolism and tumor immunotherapy

Corrigendum: T lymphocyte cell: A pivotal player in lung cancer

Corrigendum: Lipid metabolism in tumor immunology and immunotherapy

Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer

Corrigendum: Immune Tolerance Induced by Hematopoietic Stem Cell Infusion after HLA Identical Sibling Kidney Transplantation

Corrigendum: Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes

Corrigendum: Interpreting flow cytometry with caution: a case report of follicular lymphoma in leukemic phase misdiagnosed as chronic lymphocytic leukemia

Corrigendum: Exosomes: Potential biomarkers and functions in head and neck squamous cell carcinoma

Corrigendum: Identification of Microtube-Associated Biomarkers in Diffuse Large B-cell Lymphoma and Prognosis Prediction.

Corrigendum: Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma

Corrigendum: Transmembrane and coiled-coil domains 3 is a diagnostic biomarker for predicting immune checkpoint blockade efficacy in hepatocellular carcinoma

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis

Corrigendum: Exosomal CD44 transmits lymph node metastatic capacity between gastric cancer cells via YAP-CPT1A-mediated FAO reprogramming

Corrigendum: Alpha Thalassemia/Intellectual Disability X-Linked Deficiency Sensitizes Non-Small Cell Lung Cancer to Immune Checkpoint Inhibitors

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Corrigendum: Cuproptosis Key Gene FDX1 is a Prognostic Biomarker and Associated with Immune Infiltration in Glioma.

Corrigendum: Circulating cell-free DNA and IL-10 from cerebrospinal fluids aid primary vitreoretinal lymphoma diagnosis